紅太陽(000525.SZ)擬向安徽瑞邦增資5000萬元 促進其主營維生素B3產業鏈更好更快發展
格隆匯12月31日丨紅太陽(000525.SZ)公佈,根據公司“立足實業、聚焦主業”發展方針和經營需要,為增強全資子公司安徽瑞邦生物科技有限公司(“安徽瑞邦”)的資本實力,促進其主營的維生素B3產業鏈更好更快發展,提高其經營效率和盈利能力,增強紅太陽的可持續發展能力和核心競爭力,經審慎研究決定,紅太陽擬以自有資金對安徽瑞邦增資5000.00萬元。增資完成後,安徽瑞邦註冊資本由2.18億元增加至2.68億元,安徽瑞邦仍為紅太陽全資子公司。
安徽瑞邦生物科技有限公司經營範圍:生物中間體研發、銷售;煙酰胺研發、生產、銷售;自營和代理各類商品和技術的進出口業務(國家法律法規限定或禁止企業經營的除外)。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
此次紅太陽對安徽瑞邦增資不僅能夠擴大安徽瑞邦的資本實力,優化其財務結構,增強其抗風險的能力,而且有利於促進其主營的維生素B3產業鏈更好更快發展,提高其經營效率和盈利能力,增強紅太陽的可持續發展能力和核心競爭力,符合紅太陽的長遠規劃和發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.